Pharmaceutical

NorthStar and Convergent expand deal for prostate cancer drug

NorthStar Medical Radioisotopes and Convergent Therapeutics have announced an expanded strategic collaboration for CONV01-α.

Aug 15, 2024 - 04:00
NorthStar and Convergent expand deal for prostate cancer drug
NorthStar Medical Radioisotopes and Convergent Therapeutics have announced an expanded strategic collaboration for CONV01-α.
Read the original article

Tags:

Previous Article

Diabesity: Overlapping pathophysiology informs multi-indication treatment

Next Article

UAE approves BioArctic and Eisai’s Leqembi for Alzheimer’s disease

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: STAT+: Why we created a chatbot to help people at risk for eating disorders

Opinion: STAT+: Why we created a chatbot to help people...

Jun 12, 2023

Opinion: Why we created a chatbot to help people at risk for eating disorders

Opinion: Why we created a chatbot to help people at ris...

Jun 10, 2023

Listen: Explaining the E.U.’s pharma overhaul, Lilly’s booming business, & a long-awaited drug approval

Listen: Explaining the E.U.’s pharma overhaul, Lilly’s ...

Apr 27, 2023